Vanguard Group Inc Incyte Corp Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
761Shares Held
205MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.87 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.36 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$923 Million0.03% of portfolio
-
Aqr Capital Management LLC Greenwich, CT8.2MShares$767 Million0.48% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $20.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...